Joseph S. Solomkin has received honoraria and travel expenses for consulting services from Merck, Ortho-McNeill, Pfizer, Bayer, and AstraZeneca.
John E. Mazuski has received honoraria and travel expenses as a speaker for Wyeth Pharmaceuticals and as a consultant for Merck. He has been an investigator in research sponsored by Wyeth Pharmaceuticals, Bayer, Pfizer, and AstraZeneca Pharmaceuticals.
Ellen Jo Baron has been a consultant with travel and honoraria provided by Ortho-McNeil, Bayer, Merck, and AstraZeneca Pharmaceuticals. Former research projects have been funded by Merck, Pfizer, and Bristol-Myers Squibb. She owns >$10,000 worth of stock in Merck.
Robert G. Sawyer has received honoraria and travel expenses as a consultant for Pfizer and Merck.
Avery B. Nathens has received honoraria and travel expenses for consulting services from Merck, Pfizer, and Wyeth.
Joseph T. DiPiro has received honoraria and travel expenses for consulting services for Merck.
Timothy Buchman has served as a local site investigator in clinical trials sponsored by Bayer and AstraZeneca.
E. Patchen Dellinger has received honoraria and travel expenses for consulting services from Merck, Ortho-McNeill, Pfizer, Bayer, Wyeth, and AstraZeneca.
Sherwood Gorbach has received honoraria and travel expenses for consulting services from Bayer.
Anthony W. Chow has received honoraria and travel expenses for consulting services from Ortho-McNeill, Pfizer, Bayer, and AstraZeneca Pharmaceuticals.